BBA
CYT

Baker Bros. Advisors’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Baker Bros. Advisors’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,492,118
Closed -$4.11M – 115
2022
Q4 		$4.11M Sell
2,492,118
-151,522
-6% -$243K 0.02% 83
2022
Q3 		$5.08M Hold
2,643,640
– – 0.03% 79
2022
Q2 		$7.9M Buy
2,643,640
+1,831,000
+225% +$4.68M 0.04% 69
2022
Q1 		$3.06M Hold
812,640
– – 0.02% 97
2021
Q4 		$9.24M Hold
812,640
– – 0.05% 79
2021
Q3 		$14.3M Hold
812,640
– – 0.06% 69
2021
Q2 		$17.4M Buy
+812,640
New +$15.2M 0.08% 64

Other funds holding CYT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return